Market revenue in 2023 | USD 1,133.5 million |
Market revenue in 2030 | USD 2,411.4 million |
Growth rate | 11.4% (CAGR from 2023 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments |
Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, Corning Inc, Avantor Inc, BD, Eppendorf, Bio-Techne Corp, PromoCell GmbH |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell culture market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 57.93% in 2023. Horizon Databook has segmented the Canada cell culture market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
Canada’s cell culture market is witnessing rapid growth due to the increasing healthcare expenditure and expanding biopharmaceutical industry, which fueled the demand for cell culture products for research & clinical purposes. Companies with a geographic presence in Canada include STEMCELL Technologies Inc., Avantor, Thermo Fisher Scientific, Eppendorf, Bio-Rad Laboratories Canada Ltd., & others.
Furthermore, extensive R&D initiatives being undertaken by local players for cancer and other chronic diseases as a result of continuous public-private funding are anticipated to create lucrative opportunities for cell culture products in the country. In addition, increasing government investments facilitating the development of cell culture solutions and highly specialized research infrastructure in the country is anticipated to fuel market growth.
In April 2018, STEMCELL Technologies, Inc., a Canadabased cell culture products manufacturer, received USD 45 million in joint funding from the Government of Canada & British Columbia. The company used this funding to build a state-of-the-art advanced manufacturing facility to boost the manufacturing of reagents & tools to support life sciences researchers. Furthermore, government funding for stem cell research offers lucrative opportunities in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada cell culture market , including forecasts for subscribers. This country databook contains high-level insights into Canada cell culture market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account